Arylpiperazines with serotonin-3 antagonist activity: a comparative molecular field analysis

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• The 5-HT3 receptor is a key target for drugs treating conditions like nausea and irritable bowel syndrome.
• Understanding the structure-activity relationships of 5-HT3 receptor antagonists is crucial for drug design.

Purpose of the Study:

• To apply Comparative Molecular Field Analysis (CoMFA) to a series of arylpiperazine 5-HT3 receptor antagonists.
• To investigate the influence of molecular conformation, charge calculation methods, and protonation states on CoMFA model performance.

Main Methods:

• CoMFA was performed on three separate and a combined set of arylpiperazine antagonists.
• d-Tubocurarine was used as a template for molecular alignment.
• Neutral and protonated forms were analyzed using Gasteiger-Hückel, AM1, and solvated AM1 charges.

Main Results:

• Protonated structures provided superior statistical results compared to neutral forms.
• Charge calculation methods had minimal impact on the overall results.
• The CoMFA model achieved an average cross-validated r2 (r2cv) of 0.70 on the combined set of 47 compounds.
• The model accurately predicted pKi values for external test compounds with a mean agreement of 0.7 log units.

Conclusions:

• CoMFA is a viable method for modeling 5-HT3 receptor antagonists.
• Protonation state significantly influences the predictive power of CoMFA models for these compounds.
• The developed CoMFA model can interpret novel structural modifications and guide future drug design efforts.